PubRank

Lorenzo Gallon

Author PubWeight™ 22.19‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Chimerism and tolerance without GVHD or engraftment syndrome in HLA-mismatched combined kidney and hematopoietic stem cell transplantation. Sci Transl Med 2012 3.27
2 Systemic immunoregulatory and proteogenomic effects of tacrolimus to sirolimus conversion in liver transplant recipients. Hepatology 2012 1.56
3 Comparative effectiveness of liver transplant strategies for end-stage liver disease patients on renal replacement therapy. Liver Transpl 2014 1.50
4 Tolerance induction in HLA disparate living donor kidney transplantation by donor stem cell infusion: durable chimerism predicts outcome. Transplantation 2013 1.50
5 Serum soluble urokinase-type plasminogen activator receptor levels and idiopathic FSGS in children: a single-center report. Clin J Am Soc Nephrol 2013 1.20
6 Resolution of recurrent focal segmental glomerulosclerosis after retransplantation. N Engl J Med 2012 1.10
7 The human "Treg MLR": immune monitoring for FOXP3+ T regulatory cell generation. Transplantation 2009 1.06
8 Impact of anemia after renal transplantation on patient and graft survival and on rate of acute rejection. Clin J Am Soc Nephrol 2008 1.02
9 Immune reconstitution/immunocompetence in recipients of kidney plus hematopoietic stem/facilitating cell transplants. Transplantation 2015 0.96
10 Genomic biomarkers correlate with HLA-identical renal transplant tolerance. J Am Soc Nephrol 2013 0.94
11 Erythropoietin, but not the correction of anemia alone, protects from chronic kidney allograft injury. Kidney Int 2012 0.94
12 Allospecific regulatory effects of sirolimus and tacrolimus in the human mixed lymphocyte reaction. Transplantation 2011 0.93
13 Both darbepoetin alfa and carbamylated erythropoietin prevent kidney graft dysfunction due to ischemia/reperfusion in rats. Transplantation 2011 0.91
14 Intronic locus determines SHROOM3 expression and potentiates renal allograft fibrosis. J Clin Invest 2014 0.89
15 Role of beta3 integrin in acute renal allograft rejection in humans. Clin J Am Soc Nephrol 2007 0.86
16 Long-term kidney allograft function and survival in prednisone-free regimens: tacrolimus/mycophenolate mofetil versus tacrolimus/sirolimus. Clin J Am Soc Nephrol 2012 0.81
17 A decade of minimally invasive donation: experience with more than 1200 laparoscopic donor nephrectomies at a single institution. Clin Transplant 2010 0.79
18 Simulation modeling of the impact of proposed new simultaneous liver and kidney transplantation policies. Transplantation 2015 0.78
19 Mycophenolate mofetil: safety and efficacy in the prophylaxis of acute kidney transplantation rejection. Ther Clin Risk Manag 2009 0.78
20 HLA identical non-chimeric and HLA disparate chimeric renal transplant tolerance. Clin Transpl 2013 0.78
21 Role of tacrolimus combination therapy with mycophenolate mofetil in the prevention of organ rejection in kidney transplant patients. Int J Nephrol Renovasc Dis 2010 0.75
22 KDIGO Clinical Practice Guideline on the Evaluation and Care of Living Kidney Donors. Transplantation 2017 0.75
23 Chimerism and tolerance induction in kidney transplantation. Nephron 2014 0.75
24 Late conversion of tacrolimus to sirolimus in a prednisone-free immunosuppression regimen in renal transplant patients. Clin Transplant 2009 0.75
25 Summary of Kidney Disease: Improving Global Outcomes (KDIGO) Clinical Practice Guideline on the Evaluation and Care of Living Kidney Donors. Transplantation 2017 0.75